Blog - Page 1312 of 5712

FridayJul 02, 2021 11:41 am

QualityStocksNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) in Strong Position to Build TRACE Brand

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, is staking target of the burgeoning alkaline water market with its TRACE line of products, which include natural spring alkaline water and plant-based mineral water. “What is not up for debate is the very real category growth of alkaline water,” reads a recent article. “Alkaline water is an emerging category that has caught consumer attention in the last decade, growing from a $325 million market in 2013 to $631 million in 2017, on a path to contribute billions to the broader global…

FridayJul 02, 2021 11:24 am

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Raising Quality Bar with Focus on Cutting-Edge Techniques

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) has sought to address the poor reputation of legal Canadian marijuana through a relentless focus on cutting-edge cultivation techniques, thereby raising the quality bar. This distinction sets the company apart as, despite recreational marijuana being legalized across Canada in October of 2018, legal recreational sales have been slow to take off. “A Canadian government survey released in February 2021 found that 40% of country’s marijuana consumers admitted to having obtained the drug illegally since legalization – largely a result of the poor quality inherent to legal produce as well as a distinct…

FridayJul 02, 2021 11:12 am

QualityStocksNewsBreaks – Hero Technologies Inc.’s (HENC) Portfolio Leverages Premium Cultivation and Retail Assets

Hero Technologies (OTC: HENC) appears to be ideally positioned in the growing U.S. and Michigan recreational and medical marijuana markets. In Michigan, the state’s sales hit a record $115.4 million in March, a more than twofold increase over March 2020. Meanwhile, the U.S. markets are on a trajectory to reach up to $45.9 billion in annual sales by 2025, or as much as twice the level of sales projected this year. “We are growers and cultivators, developers, builders, engineers, marketers, managers all here to serve Hero Technologies Inc. as we rapidly develop the largest vertically integrated cannabis company the world…

FridayJul 02, 2021 10:53 am

Predictive Oncology Inc. (NASDAQ: POAI) Stands Strong as Innovator, Leader in Precision Medicine

Company plans to use proceeds from direct offering for business development, drug repurposing and discovery and expansion of its laboratory facilities POAI portfolio spans four different subsidiaries, including list of assets rivaling best operators in the space Predictive Oncology is strong standout in precision medicine Predictive Oncology (NASDAQ: POAI) has closed on its registered direct offering (https://ibn.fm/9buhx).The offering, which totaled $21.34 million, will be a boon for the knowledge-driven company as it continues its focus on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. Operating in the AI space, the company is looking at almost vast potential as…

FridayJul 02, 2021 10:38 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Bringing Researchers Next-Level Tools for Hard-to-Treat Diseases

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is looking to give oncology drug developers an upper hand, thereby increasing the chances of the drugs’ success from the onset. “Raising the success rate for experimental cancer drugs starts in the laboratory, where leading-edge technology could be instrumental in providing prescient insights that ultimately result in better clinical outcomes,” reads a recent article. TumorGenesis, a subsidiary of POAI, has partnered with Swedish cell culture system company Cellevate AB. “The collaboration will involve using TumorGenesis’ expertise in cancer cell culture growth…

FridayJul 02, 2021 10:20 am

QualityStocksNewsBreaks – Brain Scientific Inc.’s (BRSF) Pediatric NeuroCap Is First-of-its-Kind for Pediatric Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is bringing to market new technology that allows EEG testing to be deployed rapidly and accurately in children and adolescents. The Pediatric NeuroCap is intended to solve significant barriers limiting EEG monitoring in pediatric care. “Instead of improvising to make adult-size EEG electrodes fit pediatric patients’ smaller head circumference, Brain Scientific fully adapted its revolutionary NeuroCap to be used in children,” reads a recent article. “The Pediatric NeuroCap comes in two sizes and includes 22 integrated, pre-gelled electrodes compliant with the 10-20 international system. With the…

FridayJul 02, 2021 10:19 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Share its Drug Development Pipeline and the Company’s Progress in the Psych Investor Summit

Tryp Therapeutics will be participating in the second global Psych Investor Summit: Research and Development The virtual presentation is scheduled for July 7 from 11:50 a.m. to 12:50 p.m. EDT It will focus on the psychedelics industry, showcasing the latest research and development within the sector Mr. Greg McKee, Chairman and CEO of Tryp Therapeutics, will share information on the company, along with its drug development pipeline In an official statement dated June 24, 2021, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) confirmed that it would participate in the Psych Investor Summit: Research and Development. The virtual event, scheduled on Wednesday,…

FridayJul 02, 2021 9:59 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces the Postponement of FY2021 Earnings Report, Conference Call

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM) and A88CBD(TM), announced that the company has not filed its 10-K full-year fiscal year 2021 earnings results. As a result, the company has postponed its earnings call. The company is recognized for its flagship product, Alkaline88, which features an innovative, state-of-the-art proprietary electrolysis process and delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes. The company also offers a line of flavor-infused beverages and a line of CBD-infused products that…

FridayJul 02, 2021 9:45 am

Ideanomics Inc. (NASDAQ: IDEX) Boosts EV Tractor Acquisition to 100 Percent, Anticipating Growing Potential for Environmental Awareness in Agriculture Industry

Despite the worldwide economic difficulties imposed by the pandemic during the past year, new efforts at electric vehicle adoption are on the rise Ideanomics recently announced 100 percent acquisition of EV tractor manufacturer and distributor Solectrac Inc., which will grant it premium positioning in the agriculture industry’s growing interest in zero-emissions vehicles Ideanomics is also celebrating the launch of Technology Metals Market (“TM2”) trading using Nasdaq's cloud-deployed matching technology for real-time pricing Consumer interest in reducing the harmful effects of pollutants on the earth’s climate globally has led to a resurgence of electric-driven automotive technology in the world’s marketplace for…

FridayJul 02, 2021 9:26 am

QualityStocksNewsBreaks – Petroteq Energy Inc. ‎‎(TSX.V: PQE) (‎OTC: PQEFF) (FSE: PQCF) Outlines Planned Debt Conversions

Petroteq Energy ‎‎(TSX.V: PQE) (‎OTC: PQEFF) (FSE: PQCF), an integrated oil ‎company focused on the development and implementation of its proprietary oil-‎extraction and remediation technologies, plans to complete debt conversion transactions. According to the announcement, the transactions will involve two arm’s length lenders, to which PQEFF will issue 2,333,176 common shares for $0.094 per share. The transactions will be in satisfaction of $219,318.33, representing both accrued and unpaid interest under previously issued convertible debentures. The company also plans to complete debt conversion transactions with four directors and one former director. Those transactions will involve an additional 862,456 common shares offered…

Site Search

Company Search